Gene: MTRES1
Official Full Name: mitochondrial transcription rescue factor 1provided by HGNC
Gene Summary: Enables ribosomal large subunit binding activity and tRNA binding activity. Involved in regulation of mitochondrial transcription and rescue of stalled ribosome. Located in mitochondrial matrix. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO22797 | MTRES1 Knockout cell line (HeLa) | Human | MTRES1 | 1:3~1:6 | Negative | Online Inquiry |
KO22798 | MTRES1 Knockout cell line (HCT 116) | Human | MTRES1 | 1:2~1:4 | Negative | Online Inquiry |
KO22799 | MTRES1 Knockout cell line (HEK293) | Human | MTRES1 | 1:3~1:6 | Negative | Online Inquiry |
KO22800 | MTRES1 Knockout cell line (A549) | Human | MTRES1 | 1:3~1:4 | Negative | Online Inquiry |
MTRES1 Gene Knockout Cell Lines are precisely engineered cellular models designed to study the MTRES1 gene, a critical component implicated in various biological processes, including cellular metabolism and signaling pathways. These knockout cell lines have been developed using advanced CRISPR-Cas9 technology, which enables the specific and efficient disruption of the MTRES1 gene, allowing researchers to investigate the gene's functions, its role in disease mechanisms, and potential therapeutic targets.
The primary mechanism by which these knockout cell lines operate involves the targeted alteration of the MTRES1 gene locus, resulting in a loss of gene expression. This functional disruption facilitates the assessment of phenotypic changes, thereby offering insights into the molecular pathways influenced by MTRES1 activity. Researchers can utilize these cell lines to model diseases associated with dysregulated MTRES1, providing an invaluable tool for understanding pathophysiological processes at a cellular level.
The scientific importance of MTRES1 Gene Knockout Cell Lines extends to both basic research and clinical applications. In research settings, they are crucial for elucidating the regulatory networks and cellular behaviors driven by MTRES1. In clinical contexts, these cell lines can aid the development of targeted therapies and personalized medicine approaches by allowing for in vitro testing of drug efficacy and mechanism of action.
One of the key advantages of our MTRES1 Gene Knockout Cell Lines is their high specificity and reproducibility, ensuring that experimental results are consistent and reliable. Unlike other gene knockout models that may exhibit off-target effects or variability, our cell lines have been subjected to rigorous validation processes, providing researchers with confidence in their utility. Additionally, these cell lines are readily applicable across various experimental frameworks, making them versatile tools for a wide range of scientific inquiries.
For researchers and clinicians seeking to deepen their understanding of cellular processes and therapeutic strategies, MTRES1 Gene Knockout Cell Lines offer substantial value. They represent a state-of-the-art resource that combines accuracy with ease of use, facilitating the advancement of knowledge in molecular biology.
Our company specializes in providing high-quality biological tools backed by extensive expertise in genetic engineering and cellular biology. This commitment to precision and reliability ensures that our customers can proceed with their research and clinical endeavors with confidence in their findings.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.